...
首页> 外文期刊>Stroke: A Journal of Cerebral Circulation >Initial lesion volume is an independent predictor of clinical stroke outcome at day 90: An analysis of the Virtual International Stroke Trials Archive (VISTA) database
【24h】

Initial lesion volume is an independent predictor of clinical stroke outcome at day 90: An analysis of the Virtual International Stroke Trials Archive (VISTA) database

机译:最初的病变量是第90天临床卒中结果的独立预测因子:虚拟国际卒中试验档案库(VISTA)数据库的分析

获取原文
获取原文并翻译 | 示例

摘要

Background and Purpose-Age and National Institutes of Health Stroke Scale early after stroke onset have been identified as important determinants of final stroke outcome. We analyzed the Virtual International Stroke Trials Archive (VISTA) database to define the influence of infarct or hemorrhagic volume on clinical outcome after stroke. Methods-All patients were extracted from VISTA where infarct or hemorrhage volume information was available (n=2538; most images obtained by CT within 72 hours after stroke onset with a subset of MRI data included, volumes calculated by the ABC/2 approximation method). We used multivariate regression models to study the influence of age, National Institutes of Health Stroke Scale at baseline, and initial infarct/hemorrhage volume on clinical outcome (modified Rankin Scale, National Institutes of Health Stroke Scale, mortality) at day 90. Results-We find that in a large cohort of >1800 patients with ischemic stroke, initial lesion size is a strong and independent predictor of stroke outcome in a statistical regression model that also accounts for age and National Institutes of Health Stroke Scale at baseline (P<0.0001). The use of infarct/hemorrhage volume as an additional predictive factor further reduces the fraction of unexplained variance in outcome by approximately 15% (R of 0.41 versus 0.26 in a model without lesion volume). The predictive strength of initial lesion size is only marginally influenced by image modality or time point of image acquisition within the first 72 hours. The model was equally valid for both ischemic and hemorrhagic strokes. Conclusions-Infarct/hemorrhage volume at baseline together with age and National Institutes of Health Stroke Scale at baseline should be used in the effect analysis of future therapeutic stroke trials to improve power.
机译:背景和目的年龄以及国立卫生研究院卒中后早期的卒中量表已被确定为最终卒中预后的重要决定因素。我们分析了虚拟国际卒中试验档案库(VISTA)数据库,以定义梗死或出血量对卒中后临床结局的影响。方法-所有患者均从VISTA提取,其中可获得梗塞或出血量信息(n = 2538;大多数在卒中发作后72小时内通过CT获得的图像,包括一部分MRI数据,通过ABC / 2近似方法计算出的体积) 。我们使用多元回归模型研究了第90天时的年龄,美国国立卫生研究院卒中量表和基线时初始梗塞/出血量对临床结局的影响(改良的兰金量表,国立卫生研究院卒中量表,死亡率)。我们发现,在超过1800名缺血性卒中患者的大队列中,在统计回归模型中,初始病变大小是卒中结局的有力且独立的预测指标,该统计回归模型还考虑了年龄和美国国立卫生研究院卒中量表(P <0.0001)。 )。使用梗塞/出血量作为额外的预测因素,可将无法解释的结果差异减少约15%(R为0.41,而无病变体积的模型为0.26)。最初病变大小的预测强度仅受前72小时内的图像形态或图像采集时间的影响。该模型对缺血性和出血性中风均有效。结论基线的梗死/出血量以及年龄和基线的国立卫生研究院卒中量表应用于将来的治疗性卒中试验的疗效分析中,以提高功效。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号